Austell Laboratories Overview

  • Founded
  • 2005

  • Status
  • Private

  • Employees
  • 109

  • Latest Deal Type
  • Mezzanine

  • Latest Deal Amount
  • $9.9M

  • Investors
  • 1

Austell Laboratories General Information


Operator of a pharmaceutical company catering to the South African market. The company is engaged in producing premium and generic medicines that are clinically proven to be safe and effective and are unique in their respective disease categories, enabling patients to avail themselves of improved healthcare drugs.

Contact Information

Formerly Known As
CAMOX Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Post Office Box 1110
  • Crown Mines, 2025
  • South Africa
+27 011 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Austell Laboratories Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Mezzanine 29-Aug-2014 $9.9M 00.00 Completed Generating Revenue
To view Austell Laboratories’s complete valuation and funding history, request access »

Austell Laboratories Executive Team (5)

Name Title Board Seat Contact Info
Suhail Gani Chief Executive Officer & Founder
Younus Karolia Chief Financial Officer
Carl Witt Co-Chief Operating Officer
Melinda Badenhorst Co-Chief Operating Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Austell Laboratories Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Austell Laboratories Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vantage Capital PE/Buyout Minority 000 0000 000000 0
To view Austell Laboratories’s complete investors history, request access »

Austell Laboratories Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 0000 31-Oct-2022 0000000000 000.00 Pharmaceuticals
To view Austell Laboratories’s complete acquisitions history, request access »